An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Simulations Plus to Present at Sidoti March Small-Cap Conference
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Simulations Plus, Inc. (Nasdaq: SLP) has announced that CEO Shawn O’Connor will present at the Sidoti Small-Cap Investor Conference, scheduled for March 22-23, 2023. O’Connor's presentation is set for March 23, 2023, at 3:15 p.m. Eastern Time. The live webcast can be accessed via provided links and will be available for replay afterward. Simulations Plus is a leading provider of software and consulting services in the biosimulation market, supporting various pharmaceutical processes for over 25 years. For further details about the conference, visit the Sidoti website or contact Brian Siegel from Hayden IR.
Positive
None.
Negative
None.
LANCASTER, Calif.--(BUSINESS WIRE)--
Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced that chief executive officer Shawn O’Connor will be presenting at the Sidoti Small-Cap Investor Conference taking place virtually on March 22-23, 2023.
Mr. O’Connor will be presenting on Thursday, March 23, 2023, at 3:15 p.m. Eastern Time. The live webcast may be accessed via this link and on the Investors page of the Simulations Plus website where it will also be available for replay after the event.
For more information about the Sidoti Small-Cap Investor Conference, please visit the conference website or contact Brian Siegel from Hayden IR at brian@haydenir.com.
About Simulations Plus
Serving clients worldwide for more than 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. For more information, visit our website at www.simulations-plus.com. Follow us on Twitter | LinkedIn.
Environmental, Social, and Governance (ESG)
We focus our Environmental, Social, and Governance (ESG) efforts where we can have the most positive impact. To learn more about our latest initiatives and priorities, please visit our website to read our ESG Report
When will Simulations Plus CEO Shawn O’Connor present at the Sidoti Small-Cap Investor Conference?
Shawn O’Connor will present on March 23, 2023, at 3:15 p.m. Eastern Time.
How can I access the webcast of the Simulations Plus presentation?
The live webcast can be accessed through a link provided in the press release and will also be available for replay afterward.
What topics will be covered in Shawn O’Connor's presentation at the conference?
The specifics of the topics are not detailed in the press release, but it will likely cover the company's modeling and simulation software and services.
What is Simulations Plus known for?
Simulations Plus is a leading provider of modeling and simulation software and consulting services in the biosimulation market for the pharmaceutical industry.
How long has Simulations Plus been in business?
Simulations Plus has been serving clients worldwide for over 25 years.
